Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial

Published:2011-06-17 Issue:8 Volume:4 Page:1181-1189
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

DeCensi Andrea,Puntoni Matteo,Pruneri Giancarlo,Guerrieri-Gonzaga Aliana,Lazzeroni Matteo,Serrano Davide,Macis Debora,Johansson Harriet,Pala Oriana,Luini Alberto,Veronesi Paolo,Galimberti Viviana,Dotti Maria Cristina,Viale Giuseppe,Bonanni Bernardo

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting on patient’s body mass index (BMI) in recent clinical trials for patients with breast cancer: a systematic review;Breast Cancer Research;2024-05-22

2. Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial;Contemporary Clinical Trials;2021-08

3. Window of opportunity treatment in breast cancer;ANZ Journal of Surgery;2019-11-26

4. Ductal Carcinoma In Situ;Breast Pathology;2019-10-27

5. Diarrhea with epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients: A meta-analysis of randomized controlled trials;Critical Reviews in Oncology/Hematology;2019-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP